Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

China flag China · Delayed Price · Currency is CNY
20.15
-0.77 (-3.68%)
At close: Mar 9, 2026
-0.89%
Market Cap 3.99B
Revenue (ttm) 642.66M
Net Income (ttm) 136.31M
Shares Out 198.24M
EPS (ttm) 0.69
PE Ratio 29.12
Forward PE n/a
Dividend 0.27 (1.29%)
Ex-Dividend Date Jun 6, 2025
Volume 6,451,300
Average Volume 4,174,586
Open 20.70
Previous Close 20.92
Day's Range 20.11 - 20.90
52-Week Range 18.22 - 23.66
Beta 0.35
RSI 41.28
Earnings Date Apr 25, 2026

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Jinhua, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,118
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603896
Full Company Profile

Financial Performance

In 2024, SHA:603896's revenue was 691.68 million, a decrease of -11.81% compared to the previous year's 784.35 million. Earnings were 174.71 million, a decrease of -31.34%.

Financial Statements

News

There is no news available yet.